IL17A and non-small cell lung carcinoma: Research indicates that in early non-small cell lung cancer, the primary source of IL-17 is tumor-infiltrating γδ T cells, and a higher abundance of γδ T cells has been observed in lymph node metastases of non-small cell lung cancer patients (100).